These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7496134)
1. Glycosylation of alpha-1-proteinase inhibitor and haptoglobin in ovarian cancer: evidence for two different mechanisms. Turner GA; Goodarzi MT; Thompson S Glycoconj J; 1995 Jun; 12(3):211-8. PubMed ID: 7496134 [TBL] [Abstract][Full Text] [Related]
2. Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer. Goodarzi MT; Turner GA Clin Chim Acta; 1995 May; 236(2):161-71. PubMed ID: 7554283 [TBL] [Abstract][Full Text] [Related]
3. Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Thompson S; Dargan E; Turner GA Cancer Lett; 1992 Sep; 66(1):43-8. PubMed ID: 1451094 [TBL] [Abstract][Full Text] [Related]
4. Serum alpha-1-proteinase inhibitor with abnormal properties in ovarian cancer. Thompson S; Wong E; Cantwell BM; Turner GA Clin Chim Acta; 1990 Dec; 193(1-2):13-25. PubMed ID: 1963579 [TBL] [Abstract][Full Text] [Related]
5. Haptoglobin glycoforms in a case of carbohydrate-deficient glycoprotein syndrome. Ferens-Sieczkowska M; Midro A; Mierzejewska-Iwanowska B; Zwierz K; Katnik-Prastowska I Glycoconj J; 1999 Oct; 16(10):573-7. PubMed ID: 10972135 [TBL] [Abstract][Full Text] [Related]
6. Glycosylation and over-expression of endometriosis-associated peritoneal haptoglobin. Piva M; Moreno JI; Sharpe-Timms KL Glycoconj J; 2002 Jan; 19(1):33-41. PubMed ID: 12652078 [TBL] [Abstract][Full Text] [Related]
7. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer. Tsai HY; Boonyapranai K; Sriyam S; Yu CJ; Wu SW; Khoo KH; Phutrakul S; Chen ST Proteomics; 2011 Jun; 11(11):2162-70. PubMed ID: 21538882 [TBL] [Abstract][Full Text] [Related]
8. Haptoglobin. A potential reporter molecule for glycosylation changes in disease. Turner GA Adv Exp Med Biol; 1995; 376():231-8. PubMed ID: 8597253 [TBL] [Abstract][Full Text] [Related]
9. Carbohydrate structures of haptoglobin in sera of healthy people and a patient with congenital disorder of glycosylation. Ferens-Sieczkowska M; Olczak M Z Naturforsch C J Biosci; 2001; 56(1-2):122-31. PubMed ID: 11302201 [TBL] [Abstract][Full Text] [Related]
10. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients. Mondal G; Saroha A; Bose PP; Chatterjee BP Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286 [TBL] [Abstract][Full Text] [Related]
12. Glycoforms of six serum glycoproteins in a patient with congenital disorder of glycosylation type I. Ferens-Sieczkowska M; Zwierz K; Midro A; Katnik-Prastowska I Arch Immunol Ther Exp (Warsz); 2002; 50(1):67-73. PubMed ID: 11916311 [TBL] [Abstract][Full Text] [Related]
13. Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. Mann AC; Record CO; Self CH; Turner GA Clin Chim Acta; 1994 Jun; 227(1-2):69-78. PubMed ID: 7955423 [TBL] [Abstract][Full Text] [Related]
14. Haptoglobin and proteinase inhibitors in the blood serum of women with inflammatory, benign and neoplastic lesions of the ovary. Warwas M; Gerber J; Pietkiewicz A Neoplasma; 1986; 33(1):79-84. PubMed ID: 2421174 [TBL] [Abstract][Full Text] [Related]
15. α1-3/4 fucosylation at Asn 241 of β-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers. Park SY; Lee SH; Kawasaki N; Itoh S; Kang K; Hee Ryu S; Hashii N; Kim JM; Kim JY; Hoe Kim J Int J Cancer; 2012 May; 130(10):2366-76. PubMed ID: 21780104 [TBL] [Abstract][Full Text] [Related]
16. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Thompson S; Turner GA Br J Cancer; 1987 Nov; 56(5):605-10. PubMed ID: 3426924 [TBL] [Abstract][Full Text] [Related]
17. Reproducible and sensitive determination of charged oligosaccharides from haptoglobin by PNGase F digestion and HPAEC/PAD analysis: glycan composition varies with disease. Goodarzi MT; Turner GA Glycoconj J; 1998 May; 15(5):469-75. PubMed ID: 9881748 [TBL] [Abstract][Full Text] [Related]
18. Postmortem diagnosis of diabetic metabolic derangement: elevated alpha 1-antitrypsin and haptoglobin glycosylation levels as an index of antemortem hyperglycemia. Ritz S; Mehlan G; Martz W J Forensic Sci; 1996 Jan; 41(1):94-100. PubMed ID: 8934703 [TBL] [Abstract][Full Text] [Related]
19. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640 [TBL] [Abstract][Full Text] [Related]
20. Insights on N-glycosylation of human haptoglobin and its association with cancers. Zhang S; Shang S; Li W; Qin X; Liu Y Glycobiology; 2016 Jul; 26(7):684-692. PubMed ID: 26873173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]